[The preleukemic syndrome. Dysplasia hemopoietica]

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Leukemia·2016

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Leukemia·2015

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Leukemia·2015

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

Leukemia·2014

[Efficacy of sacituzumab govitecan in multi-treated metastatic breast cancer and clinical management of oligoprogressions.]

Recenti progressi in medicina·2026

[Sustained clinical benefit with sacituzumab govitecan in metastatic triple-negative breast cancer with extensive cutaneous involvement.]

Recenti progressi in medicina·2026

[Long-term treatment with sacituzumab govitecan in a patient with brain metastases from triple-negative breast cancer, PD-L1-negative, BRCA1/2 wild-type.]

Recenti progressi in medicina·2026

[Epidemiology and burden on the National Health Service of cardiomyopathy associated with transthyretin amyloidosis based on administrative health data.]

Recenti progressi in medicina·2026

The struggle for a unified specialty in general practice, primary health care and community medicine in Italy.

Recenti progressi in medicina·2026

[A season of healthcare reforms?]

Recenti progressi in medicina·2026

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain.

Cureus·2026

A Study on the Clinical Phenotypes and Genetic Analysis of ENG Variants in Four Hereditary Hemorrhagic Telangiectasia Type 1 Families.

Human mutation·2026

HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation.

Transplantation proceedings·2026

Does Tranexamic acid fix all bleeding in surgery?

Journal of the National Medical Association·2026

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A,-B, -C, -DRB1, and -DQB1 in 263,542 Thai voluntary stem cell donors.

Human immunology·2026

Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.

Clinical pharmacokinetics·2026

Related Experiment Videos

[The preleukemic syndrome. Dysplasia hemopoietica]

Related Concept Videos

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

[Efficacy of sacituzumab govitecan in multi-treated metastatic breast cancer and clinical management of oligoprogressions.]

[Sustained clinical benefit with sacituzumab govitecan in metastatic triple-negative breast cancer with extensive cutaneous involvement.]

[Long-term treatment with sacituzumab govitecan in a patient with brain metastases from triple-negative breast cancer, PD-L1-negative, BRCA1/2 wild-type.]

[Epidemiology and burden on the National Health Service of cardiomyopathy associated with transthyretin amyloidosis based on administrative health data.]

The struggle for a unified specialty in general practice, primary health care and community medicine in Italy.

[A season of healthcare reforms?]

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain.

A Study on the Clinical Phenotypes and Genetic Analysis of ENG Variants in Four Hereditary Hemorrhagic Telangiectasia Type 1 Families.

HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation.

Does Tranexamic acid fix all bleeding in surgery?

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A,-B, -C, -DRB1, and -DQB1 in 263,542 Thai voluntary stem cell donors.

Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.

Related Experiment Videos

[The preleukemic syndrome. Dysplasia hemopoietica]

Related Concept Videos

Related Articles